Bicycle Therapeutics Plc Profit Margin

The latest profit margin for BCYC is -311.11% as of June 2026. That compares with -1257.0% in the prior-year period — up 75.3% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Bicycle Therapeutics Plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, BCYC's profit margin moved from -1257.0% to -311.11% — a 75.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bicycle Therapeutics Plc's valuation or profitability profile.

Against Healthcare companies, BCYC currently prints -311.11% for profit margin, while the sector average sits near 15.29%. That is roughly 2134.3% below the sector mean. Large gaps often invite a closer look at Bicycle Therapeutics Plc's growth, margins, and balance sheet.

Profit Margin shows how effectively Bicycle Therapeutics Plc converts resources into returns. At -311.11%, BCYC may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1257.0% in the prior-year period — up 75.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BCYC's profit margin (-311.11%), review year-over-year change from -1257.0%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.